{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T11:05:13Z","timestamp":1769252713936,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Science Centre in Poland","award":["2020\/39\/O\/NZ4\/01732"],"award-info":[{"award-number":["2020\/39\/O\/NZ4\/01732"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>5-aminosalicylic acid (5-ASA) is a first-line treatment for maintaining colitis remission. It is a highly effective, safe, and well-tolerated drug with anti-inflammatory and chemo-preventive properties. While patients with primary sclerosing cholangitis (PSC) with concomitant ulcerative colitis are treated with 5-ASA, the molecular mechanisms underlying the drug\u2019s chemo-preventive effects are not entirely understood. We previously reported that bile acids and lipopolysaccharide-induced miR-155 expression was associated with downregulating mismatch repair (MMR) proteins in CACO-2 cell lines. Therefore, in this investigation, a set of in vitro functional studies was performed to show the possible mechanisms behind the epigenetic relationship between miR-155 and 5-ASA\u2019s prevention of high microsatellite instability (MSI-H). In transient transfection with miR-155Mimic, which behaves like endogenous miRNA, we confirmed the relationships between miR-155 and its target MMR in three human intestinal epithelial cell lines: CACO-2, NCM460D and HT-29. We have shown, for the first time, that 5-ASA modulates MLH1, MSH2, MSH6 in miR-155 transfected cells. These findings underline that chemoprotective 5-ASA therapy can effectively attenuate the expression of miR-155 and potentially prevent a development of MSI-H in a subset of colorectal cancers associated with PSC.<\/jats:p>","DOI":"10.1007\/s13105-024-01033-y","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T06:02:31Z","timestamp":1720591351000},"page":"573-583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Modulation of miR-155-5p signalling via 5-ASA for the prevention of high microsatellite instability: an in vitro study using human epithelial cell lines"],"prefix":"10.1007","volume":"80","author":[{"given":"Monika","family":"Adamowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Abramczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Kilanczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Milkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"\u0141aba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Milkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Kempinska-Podhorodecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"issue":"1","key":"1033_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/cancers10010026","volume":"10","author":"K Inamura","year":"2018","unstructured":"Inamura K (2018) Colorectal cancers: an update on their Molecular Pathology. Cancers (Basel) 10(1):26. https:\/\/doi.org\/10.3390\/cancers10010026","journal-title":"Cancers (Basel)"},{"key":"1033_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.biopha.2016.09.099","volume":"84","author":"A Mohammadi","year":"2016","unstructured":"Mohammadi A, Mansoori B, Baradaran B (2016) The role of MicroRNAs in Colorectal Cancer. Biomed Pharmacother 84:705\u2013713. https:\/\/doi.org\/10.1016\/j.biopha.2016.09.099","journal-title":"Biomed Pharmacother"},{"issue":"13","key":"1033_CR3","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","volume":"76","author":"AA Svoronos","year":"2016","unstructured":"Svoronos AA, Engelman DM, Slack FJ (2016) OncomiR or tumor suppressor? The duplicity of MicroRNAs in Cancer. Cancer Res 76(13):3666\u20133670. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0359","journal-title":"Cancer Res"},{"issue":"2","key":"1033_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1161\/ATVBAHA.112.300068","volume":"33","author":"G Liu","year":"2013","unstructured":"Liu G, Abraham E (2013) MicroRNAs in Immune Response and Macrophage polarization. Arterioscler Thromb Vasc Biol 33(2):170\u2013177. https:\/\/doi.org\/10.1161\/ATVBAHA.112.300068","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9904","key":"1033_CR5","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","volume":"382","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield GM, Karlsen TH, Lindor KD, Adams DH (2013) Primary sclerosing Cholangitis. Lancet 382(9904):1587\u20131599. https:\/\/doi.org\/10.1016\/S0140-6736(13)60096-3","journal-title":"Lancet"},{"issue":"8","key":"1033_CR6","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","volume":"152","author":"TJ Weism\u00fcller","year":"2017","unstructured":"Weism\u00fcller TJ, Strassburg CP, Trivedi PJ, Hirschfield GM, Trivedi PJ, Bergquist A, Said K, Imam M, Lazaridis KN, Juran BD et al (2017) Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing Cholangitis. Gastroenterology 152(8):1975\u20131984e8. https:\/\/doi.org\/10.1053\/j.gastro.2017.02.038","journal-title":"Gastroenterology"},{"issue":"9","key":"1033_CR7","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/ibd.20886","volume":"15","author":"MMH Claessen","year":"2009","unstructured":"Claessen MMH, Lutgens MWMD, Van Buuren HR, Oldenburg B, Stokkers PCF, Van Der Woude CJ, Hommes DW, De Jong DJ, Dijkstra G, Van Bodegraven AA et al (2009) More right-sided IBD-Associated Colorectal Cancer in patients with primary sclerosing Cholangitis. Inflamm Bowel Dis 15(9):1331\u20131336. https:\/\/doi.org\/10.1002\/ibd.20886","journal-title":"Inflamm Bowel Dis"},{"key":"1033_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fonc.2013.00130","volume":"3","author":"CV Rao","year":"2013","unstructured":"Rao CV, Yamada HY (2013) Genomic instability and Colon carcinogenesis: from the perspective of genes. Front Oncol 3:130. https:\/\/doi.org\/10.3389\/fonc.2013.00130","journal-title":"Front Oncol"},{"issue":"6","key":"1033_CR9","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","volume":"138","author":"CR Boland","year":"2010","unstructured":"Boland CR, Goel A (2010) Microsatellite instability in Colorectal Cancer. Gastroenterology 138(6):2073\u20132087. e3","journal-title":"Gastroenterology"},{"issue":"41","key":"1033_CR10","doi-asserted-by":"publisher","first-page":"16170","DOI":"10.1073\/pnas.0703942104","volume":"104","author":"M Gironella","year":"2007","unstructured":"Gironella M, Seux M, Xie M-J, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang K-T et al (2007) Tumor protein 53-Induced nuclear protein 1 expression is repressed by MiR-155, and its restoration inhibits pancreatic Tumor Development. Proc Natl Acad Sci U S A 104(41):16170\u201316175. https:\/\/doi.org\/10.1073\/pnas.0703942104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1033_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","volume":"9","author":"N Yanaihara","year":"2006","unstructured":"Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T et al (2006) Unique MicroRNA Molecular profiles in Lung Cancer diagnosis and prognosis. Cancer Cell 9(3):189\u2013198. https:\/\/doi.org\/10.1016\/j.ccr.2006.01.025","journal-title":"Cancer Cell"},{"key":"1033_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102922","author":"KMT Arif","year":"2020","unstructured":"Arif KMT, Elliott EK, Haupt LM, Griffiths LR (2020) Regulatory mechanisms of Epigenetic MiRNA relationships in Human Cancer and potential as therapeutic targets. Cancers. https:\/\/doi.org\/10.3390\/cancers12102922","journal-title":"Cancers"},{"issue":"3","key":"1033_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4103\/0973-1482.175432","volume":"14","author":"H Cao","year":"2018","unstructured":"Cao H, Huang S, Liu A, Chen Z (2018) Up-Regulated expression of MiR-155 in human Colonic Cancer. J Cancer Res Ther 14(3):604\u2013607. https:\/\/doi.org\/10.4103\/0973-1482.175432","journal-title":"J Cancer Res Ther"},{"key":"1033_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094905","author":"M Adamowicz","year":"2022","unstructured":"Adamowicz M, Stukan I, Milkiewicz P, Bialek A, Milkiewicz M, Kempinska-Podhorodecka A (2022) Modulation of Mismatch Repair and the SOCS1\/P53 Axis by MicroRNA-155 in the Colon of patients with primary sclerosing Cholangitis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23094905","journal-title":"Int J Mol Sci"},{"key":"1033_CR15","doi-asserted-by":"publisher","unstructured":"Kempinska-Podhorodecka A, Milkiewicz M, Wasik U, Ligocka J, Zawadzki M, Krawczyk M, Milkiewicz P (2017) Decreased expression of vitamin D receptor affects an Immune response in primary biliary cholangitis via the VDR-MiRNA155-SOCS1 pathway. Int J Mol Sci 18(2). https:\/\/doi.org\/10.3390\/ijms18020289","DOI":"10.3390\/ijms18020289"},{"issue":"15","key":"1033_CR16","doi-asserted-by":"publisher","first-page":"6982","DOI":"10.1073\/pnas.1002472107","volume":"107","author":"N Valeri","year":"2010","unstructured":"Valeri N, Gasparini P, Fabbri M, Braconi C, Veronese A, Lovat F, Adair B, Vannini I, Fanini F, Bottoni A et al (2010) Modulation of Mismatch Repair and genomic Stability by MiR-155. Proc Natl Acad Sci U S A 107(15):6982\u20136987. https:\/\/doi.org\/10.1073\/pnas.1002472107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5109","key":"1033_CR17","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.8484122","volume":"260","author":"SN Thibodeau","year":"1993","unstructured":"Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in Cancer of the proximal Colon. Sci (80-) 260(5109):816\u2013819","journal-title":"Sci (80-)"},{"issue":"4","key":"1033_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1200\/JCO.18.00283","volume":"37","author":"A Latham","year":"2019","unstructured":"Latham A, Srinivasan P, Kemel Y, Shia J, Bandlamudi C, Mandelker D, Middha S, Hechtman J, Zehir A, Dubard-Gault M et al (2019) Microsatellite instability is Associated with the Presence of Lynch Syndrome Pan-cancer. J Clin Oncol 37(4):286\u2013295. https:\/\/doi.org\/10.1200\/JCO.18.00283","journal-title":"J Clin Oncol"},{"issue":"22","key":"1033_CR19","first-page":"5248","volume":"58","author":"CR Boland","year":"1998","unstructured":"Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN et al (1998) A National Cancer Institute Workshop on microsatellite instability for Cancer detection and familial predisposition: development of International Criteria for the determination of microsatellite instability in Colorectal Cancer. Cancer Res 58(22):5248\u20135257","journal-title":"Cancer Res"},{"issue":"12","key":"1033_CR20","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1111\/j.1572-0241.2000.03342.x","volume":"95","author":"RP MacDermott","year":"2000","unstructured":"MacDermott RP (2000) Progress in understanding the mechanisms of Action of 5-Aminosalicylic acid. Am J Gastroenterol 95(12):3343\u20133345. https:\/\/doi.org\/10.1111\/j.1572-0241.2000.03342.x","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1033_CR21","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.18632\/oncotarget.13715","volume":"8","author":"X Qiu","year":"2017","unstructured":"Qiu X, Ma J, Wang K, Zhang H (2017) Chemopreventive effects of 5-Aminosalicylic acid on inflammatory bowel Disease-Associated Colorectal Cancer and Dysplasia: a systematic review with Meta-analysis. Oncotarget 8(1):1031\u20131045. https:\/\/doi.org\/10.18632\/oncotarget.13715","journal-title":"Oncotarget"},{"issue":"7","key":"1033_CR22","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/BF02054445","volume":"39","author":"R Schoonjans","year":"1996","unstructured":"Schoonjans R, De Vos M, Schelfhout AM, Praet M, Elewaut A (1996) Distribution and concentrations of 5-Aminosalicylic acid in Rectosigmoid Biopsy Specimens after rectal administration. Dis Colon Rectum 39(7):788\u2013793. https:\/\/doi.org\/10.1007\/BF02054445","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"1033_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1365-2168.1997.02587.x","volume":"84","author":"AD Stockdale","year":"1997","unstructured":"Stockdale AD, Biswas A (1997) Long-Term Control of Radiation Proctitis Following Treatment with Sucralfate Enemas. Br J Surg 84(3):379. https:\/\/doi.org\/10.1046\/j.1365-2168.1997.02587.x","journal-title":"Br J Surg"},{"key":"1033_CR24","doi-asserted-by":"publisher","unstructured":"Szatkowski P, Krzysciak W, Mach T, Owczarek D, Brzozowski B, Szczeklik K (2020) Nuclear Factor-\u039aB - importance, induction of inflammation, and effects of pharmacological modulators in Crohn\u2019s Disease. J Physiol Pharmacol 71(4). https:\/\/doi.org\/10.26402\/jpp.2020.4.01","DOI":"10.26402\/jpp.2020.4.01"},{"key":"1033_CR25","doi-asserted-by":"publisher","unstructured":"Krajewska JB, Pietruszka P, Tomczyk D, Chen C, Owczarek A, Karolewicz B, Czapor-Irzabek H, Gorniak A, Fichna J (2019) Evaluation of the Effect of liposomes loaded with chlorogenic acid in treatment of 2,4,6-Trinitrobenzenesulfonic Acid-Induced Murine Colitis. J Physiol Pharmacol off J Pol Physiol Soc 70(2). https:\/\/doi.org\/10.26402\/jpp.2019.2.10","DOI":"10.26402\/jpp.2019.2.10"},{"issue":"8","key":"1033_CR26","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1158\/1940-6207.CAPR-17-0382","volume":"11","author":"S Parenti","year":"2018","unstructured":"Parenti S, Montorsi L, Fantini S, Mammoli F, Gemelli C, Atene CG, Losi L, Frassineti C, Calabretta B, Tagliafico E et al (2018) KLF4 mediates the Effect of 5-ASA on the \u03b2-Catenin pathway in Colon cancer cells. Cancer Prev Res (Phila) 11(8):503\u2013510. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-17-0382","journal-title":"Cancer Prev Res (Phila)"},{"issue":"9","key":"1033_CR27","doi-asserted-by":"publisher","first-page":"17972","DOI":"10.3390\/ijms140917972","volume":"14","author":"C Stolfi","year":"2013","unstructured":"Stolfi C, De Simone V, Pallone F, Monteleone G (2013) Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer. Int J Mol Sci 14(9):17972\u201317985. https:\/\/doi.org\/10.3390\/ijms140917972","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1033_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1365-2036.2009.04149.x","volume":"31","author":"S Parenti","year":"2010","unstructured":"Parenti S, Ferrarini F, Zini R, Montanari M, Losi L, Canovi B, Ferrari S, Grande A (2010) Mesalazine inhibits the Beta-catenin signalling pathway acting through the Upregulation of Mu-Protocadherin Gene in Colo-rectal Cancer cells. Aliment Pharmacol Ther 31(1):108\u2013119. https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04149.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1033_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1365-2036.2009.04195.x","volume":"31","author":"A Lyakhovich","year":"2010","unstructured":"Lyakhovich A, Gasche CS, Review (2010) Molecular chemoprevention of colorectal malignancy by Mesalazine. Aliment Pharmacol Ther 31(2):202\u2013209. https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04195.x","journal-title":"Aliment Pharmacol Ther"},{"key":"1033_CR30","doi-asserted-by":"publisher","unstructured":"Adamowicz M, Milkiewicz P, Kempinska-Podhorodecka A (2021) 5-Aminosalicylic acid inhibits the expression of OncomiRs and pro-inflammatory MicroRNAs: an in Vitro Study. J Physiol Pharmacol 72(4). https:\/\/doi.org\/10.26402\/jpp.2021.4.04","DOI":"10.26402\/jpp.2021.4.04"},{"key":"1033_CR31","doi-asserted-by":"publisher","unstructured":"Lan H, Zhang L-Y, He W, Li W-Y, Zeng Z, Qian B, Wang C, Song J-L (2021) Sinapic acid alleviated inflammation-Induced Intestinal Epithelial Barrier Dysfunction in Lipopolysaccharide- (LPS-) treated Caco-2 cells. Mediators Inflamm 2021(5514075). https:\/\/doi.org\/10.1155\/2021\/5514075","DOI":"10.1155\/2021\/5514075"},{"key":"1033_CR32","doi-asserted-by":"publisher","unstructured":"Lin T-Y, Fan C-W, Maa M-C, Leu T-H (2015) Lipopolysaccharide-Promoted Proliferation of Caco-2 Cells Is Mediated by c-Src Induction and ERK Activation. BioMedicine 5 (1), 5. https:\/\/doi.org\/10.7603\/s40681-015-0005-x","DOI":"10.7603\/s40681-015-0005-x"},{"issue":"9","key":"1033_CR33","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1017\/S0007114511007227","volume":"108","author":"MA Panaro","year":"2012","unstructured":"Panaro MA, Carofiglio V, Acquafredda A, Cavallo P, Cianciulli A (2012) Anti-inflammatory effects of Resveratrol Occur via Inhibition of Lipopolysaccharide-Induced NF-\u039aB activation in Caco-2 and SW480 human Colon cancer cells. Br J Nutr 108(9):1623\u20131632. https:\/\/doi.org\/10.1017\/S0007114511007227","journal-title":"Br J Nutr"},{"issue":"2","key":"1033_CR34","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1038\/emm.2017.282","volume":"50","author":"C Chelakkot","year":"2018","unstructured":"Chelakkot C, Choi Y, Kim D-K, Park HT, Ghim J, Kwon Y, Jeon J, Kim M-S, Jee Y-K, Gho YS et al (2018) Akkermansia Muciniphila-Derived Extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp Mol Med 50(2):e450. https:\/\/doi.org\/10.1038\/emm.2017.282","journal-title":"Exp Mol Med"},{"issue":"1","key":"1033_CR35","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","volume":"50","author":"MMH Claessen","year":"2009","unstructured":"Claessen MMH, Vleggaar FP, Tytgat KMAJ, Siersema PD, van Buuren HR (2009) High lifetime risk of Cancer in Primary Sclerosing Cholangitis. J Hepatol 50(1):158\u2013164. https:\/\/doi.org\/10.1016\/j.jhep.2008.08.013","journal-title":"J Hepatol"},{"issue":"4","key":"1033_CR36","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/gut.48.4.526","volume":"48","author":"JA Eaden","year":"2001","unstructured":"Eaden JA, Abrams KR, Mayberry JF (2001) The risk of Colorectal Cancer in Ulcerative Colitis: a Meta-analysis. Gut 48(4):526\u2013535. https:\/\/doi.org\/10.1136\/gut.48.4.526","journal-title":"Gut"},{"key":"1033_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/1477-7819-12-164","volume":"12","author":"H Ajouz","year":"2014","unstructured":"Ajouz H, Mukherji D, Shamseddine A (2014) Secondary bile acids: an underrecognized cause of Colon cancer. World J Surg Oncol 12:164. https:\/\/doi.org\/10.1186\/1477-7819-12-164","journal-title":"World J Surg Oncol"},{"issue":"18","key":"1033_CR38","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.3390\/cells11182880","volume":"11","author":"M Adamowicz","year":"2022","unstructured":"Adamowicz M, Kempinska-Podhorodecka A, Abramczyk J, Banales JM, Milkiewicz P, Milkiewicz M (2022) Suppression of hepatic PPAR\u03b1 in primary biliary cholangitis is modulated by MiR-155. Cells 11(18):2880","journal-title":"Cells"},{"issue":"5","key":"1033_CR39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/08830180903093796","volume":"28","author":"E Tili","year":"2009","unstructured":"Tili E, Croce CM, Michaille J-J (2009) MiR-155: on the crosstalk between inflammation and Cancer. Int Rev Immunol 28(5):264\u2013284. https:\/\/doi.org\/10.1080\/08830180903093796","journal-title":"Int Rev Immunol"},{"issue":"7518","key":"1033_CR40","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature13438","volume":"513","author":"B Zhang","year":"2014","unstructured":"Zhang B, Wang J, Wang X, Zhu J, Liu Q, Shi Z, Chambers MC, Zimmerman LJ, Shaddox KF, Kim S et al (2014) Proteogenomic characterization of human Colon and rectal Cancer. Nature 513(7518):382\u2013387. https:\/\/doi.org\/10.1038\/nature13438","journal-title":"Nature"},{"key":"1033_CR41","doi-asserted-by":"publisher","unstructured":"Gut 2015, 64 (12), 1905 LP \u2013 1912. https:\/\/doi.org\/10.1136\/gutjnl-2014-307663","DOI":"10.1136\/gutjnl-2014-307663"},{"issue":"1","key":"1033_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/ibd\/izy279","volume":"25","author":"CD Minacapelli","year":"2019","unstructured":"Minacapelli CD, Bajpai M, Geng X, Van Gurp J, Poplin E, Amenta PS, Brant SR, Das KM (2019) MiR-206 as a biomarker for response to Mesalamine Treatment in Ulcerative Colitis. Inflamm Bowel Dis 25(1):78\u201384. https:\/\/doi.org\/10.1093\/ibd\/izy279","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"1033_CR43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/BF02722955","volume":"32","author":"MP Moyer","year":"1996","unstructured":"Moyer MP, Manzano LA, Merriman RL, Stauffer JS, Tanzer LR (1996) NCM460, a normal human Colon mucosal epithelial cell line. Vitr Cell Dev Biol - Anim 32(6):315\u2013317. https:\/\/doi.org\/10.1007\/BF02722955","journal-title":"Vitr Cell Dev Biol - Anim"},{"issue":"6","key":"1033_CR44","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.bbagen.2013.12.024","volume":"1840","author":"G Alcarraz-Viz\u00e1n","year":"2014","unstructured":"Alcarraz-Viz\u00e1n G, S\u00e1nchez-Tena S, Moyer MP, Cascante M (2014) Validation of NCM460 cell model as control in Antitumor Strategies targeting Colon adenocarcinoma metabolic reprogramming: trichostatin A as a case study. Biochim Biophys Acta 1840(6):1634\u20131639. https:\/\/doi.org\/10.1016\/j.bbagen.2013.12.024","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1033_CR45","first-page":"148","volume":"145","author":"H Kim","year":"1994","unstructured":"Kim H, Jen J, Vogelstein B, Hamilton SR (1994) Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 145(1):148\u2013156","journal-title":"Am J Pathol"},{"issue":"1","key":"1033_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1053\/j.gastro.2007.04.044","volume":"133","author":"MA Jenkins","year":"2007","unstructured":"Jenkins MA, Hayashi S, O\u2019Shea A-M, Burgart LJ, Smyrk TC, Shimizu D, Waring PM, Ruszkiewicz AR, Pollett AF, Redston M et al (2007) Pathology features in Bethesda guidelines predict colorectal Cancer microsatellite instability: a Population-based study. Gastroenterology 133(1):48\u201356. https:\/\/doi.org\/10.1053\/j.gastro.2007.04.044","journal-title":"Gastroenterology"},{"issue":"12","key":"1033_CR47","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/BF02555362","volume":"29","author":"JP Mecklin","year":"1986","unstructured":"Mecklin JP, Sipponen P, J\u00e4rvinen HJ (1986) Histopathology of Colorectal carcinomas and adenomas in Cancer Family Syndrome. Dis Colon Rectum 29(12):849\u2013853. https:\/\/doi.org\/10.1007\/BF02555362","journal-title":"Dis Colon Rectum"},{"key":"1033_CR48","unstructured":"Gasche C, M\u00f6slein G, Vasen HF, Lubinski J, Karner-Hanusch J, Niv Y (2017) MesaCAPP: Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome"},{"key":"1033_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1476-4598-5-29","volume":"5","author":"E Bandr\u00e9s","year":"2006","unstructured":"Bandr\u00e9s E, Cubedo E, Agirre X, Malumbres R, Z\u00e1rate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monz\u00f3 M et al (2006) Identification by real-time PCR of 13 mature MicroRNAs differentially expressed in Colorectal Cancer and Non-tumoral tissues. Mol Cancer 5:29. https:\/\/doi.org\/10.1186\/1476-4598-5-29","journal-title":"Mol Cancer"},{"issue":"10","key":"1033_CR50","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/gut.2008.167817","volume":"58","author":"EKO Ng","year":"2009","unstructured":"Ng EKO, Chong WWS, Jin H, Lam EKY, Shin VY, Yu J, Poon TCW, Ng SSM, Sung JJY (2009) Differential expression of MicroRNAs in plasma of patients with colorectal Cancer: a potential marker for Colorectal Cancer Screening. Gut 58(10):1375\u20131381. https:\/\/doi.org\/10.1136\/gut.2008.167817","journal-title":"Gut"},{"issue":"7","key":"1033_CR51","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu C-G, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M et al (2006) A MicroRNA expression signature of human solid tumors defines Cancer Gene targets. Proc Natl Acad Sci U S A 103(7):2257\u20132261. https:\/\/doi.org\/10.1073\/pnas.0510565103","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-024-01033-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-024-01033-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-024-01033-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T07:46:19Z","timestamp":1729755979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-024-01033-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1033"],"URL":"https:\/\/doi.org\/10.1007\/s13105-024-01033-y","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Pomeranian Medical University (KB0012\/44\/2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}